The chemical class of α-FR activators constitutes a critical group of compounds essential for regulating the activity of α-Folate Receptor (α-FR), a receptor that plays a pivotal role in cellular processes relying on folate metabolism. Folate, the primary activator within this class, engages with the extracellular domain of α-FR, prompting receptor clustering and initiating downstream signaling cascades crucial for various cellular functions. This interaction underscores the intricate nature of cellular processes dependent on folate metabolism and establishes α-FR activators as key players in modulating these pathways. Beyond folate itself, numerous folate analogs contribute to the activation of α-FR. Methotrexate, a widely recognized anticancer drug, serves as one such analog. Its interaction with α-FR not only inhibits dihydrofolate reductase, a key enzyme in the folate pathway, but also disrupts polyamine biosynthesis. Similarly, Pemetrexed, Pralatrexate, Trimetrexate, Edatrexate, Raltitrexed, and Lometrexol, among others, exhibit α-FR activation properties by influencing folate-dependent pathways. These compounds collectively emphasize the diversity within the α-FR activator class, showcasing their ability to modulate cellular processes through various mechanisms.
The competitive inhibition of enzymes involved in the folate pathway is a common theme among α-FR activators. Additionally, interference with polyamine biosynthesis represents another avenue through which these activators exert their influence, ultimately leading to elevated intracellular folate levels. The intricate interplay of these compounds with cellular processes provides valuable insights into the regulatory mechanisms of folate metabolism. The multifaceted nature of α-FR activators not only highlights their significance in fundamental cellular functions but also suggests their potential in advancing our comprehension of cellular development. In summary, the α-FR activator chemical class, consisting of folate and its analogs, stands as a crucial set of compounds that intricately modulate cellular processes dependent on folate metabolism.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Folic Acid | 59-30-3 | sc-204758 | 10 g | $73.00 | 2 | |
Folate activates α-FR by binding to its extracellular domain. This interaction facilitates receptor clustering, initiating downstream signaling crucial for cellular processes reliant on folate metabolism. The regulatory role of Folate in α-FR activation underscores its significance in orchestrating the intricate processes involved in cellular function. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate activates α-FR by competitively inhibiting dihydrofolate reductase. This inhibition leads to increased intracellular folate levels, promoting α-FR clustering and downstream signaling. The impact of Methotrexate on α-FR highlights its role in modulating cellular processes dependent on folate metabolism. | ||||||
Pemetrexed Disodium | 150399-23-8 | sc-219564 | 10 mg | $136.00 | 5 | |
Pemetrexed activates α-FR by inhibiting multiple folate-dependent enzymes. This inhibition increases intracellular folate levels, promoting α-FR clustering and downstream signaling. The influence of Pemetrexed on α-FR underscores its role in modulating cellular processes dependent on folate metabolism. | ||||||
Folotyn | 146464-95-1 | sc-364491 sc-364491A | 10 mg 50 mg | $480.00 $1455.00 | ||
Pralatrexate activates α-FR by competitively inhibiting dihydrofolate reductase. This inhibition increases intracellular folate levels, promoting α-FR clustering and downstream signaling. The impact of Pralatrexate on α-FR highlights its role in modulating cellular processes dependent on folate metabolism. | ||||||
Raltitrexed | 112887-68-0 | sc-219933 | 10 mg | $146.00 | ||
Raltitrexed activates α-FR by inhibiting thymidylate synthase. This inhibition increases intracellular folate levels, promoting α-FR clustering and downstream signaling. The influence of Raltitrexed on α-FR underscores its role in modulating cellular processes dependent on folate metabolism. | ||||||
Difluoromethylornithine | 70052-12-9 | sc-204723 sc-204723A sc-204723B sc-204723C sc-204723D sc-204723E | 10 mg 25 mg 100 mg 250 mg 1 g 5 g | $59.00 $133.00 $161.00 $317.00 $983.00 $4821.00 | 2 | |
Eflornithine activates α-FR by interfering with polyamine biosynthesis. This disruption increases intracellular folate levels, promoting α-FR clustering and downstream signaling. The impact of Eflornithine on α-FR highlights its role in modulating cellular processes dependent on folate metabolism. | ||||||